These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 17899293)

  • 61. Tumour size as a predictor of axillary node metastases in patients with breast cancer.
    Laura S; Coombs NJ; Ung O; Boyages J
    ANZ J Surg; 2006 Nov; 76(11):1002-6. PubMed ID: 17054550
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Distinction between isolated tumor cells and micrometastases in breast cancer: is it reliable and useful?
    de Mascarel I; MacGrogan G; Debled M; Brouste V; Mauriac L
    Cancer; 2008 Apr; 112(8):1672-8. PubMed ID: 18286534
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The predictive value of micrometastasis in nonsentinel lymph nodes.
    Glasgow PD; Satchidanand N; Kowdley GC
    Am Surg; 2012 Jun; 78(6):669-74. PubMed ID: 22643262
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Axillary lymph node micrometastases in invasive breast cancer: national figures on incidence and overall survival.
    Grabau D; Jensen MB; Rank F; Blichert-Toft M
    APMIS; 2007 Jul; 115(7):828-37. PubMed ID: 17614850
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation.
    Alkuwari E; Auger M
    Cancer; 2008 Apr; 114(2):89-93. PubMed ID: 18286535
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer.
    Van den Eynden GG; Van der Auwera I; Van Laere SJ; Huygelen V; Colpaert CG; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
    Br J Cancer; 2006 Nov; 95(10):1362-6. PubMed ID: 17088912
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
    Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Value of cancer-related oncoprotein expression as prognostic factors in breast-cancer with one to three axillary lymph nodes positive].
    Zhang G; Tsuda H; Adachi I; Fukutomi T; Yamamoto H; Hirohashi S
    Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():66-74. PubMed ID: 8702314
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort.
    Elkin EB; Hurria A; Mitra N; Schrag D; Panageas KS
    J Clin Oncol; 2006 Jun; 24(18):2757-64. PubMed ID: 16782916
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study.
    Crabb SJ; Bajdik CD; Leung S; Speers CH; Kennecke H; Huntsman DG; Gelmon KA
    Breast Cancer Res; 2008; 10(1):R6. PubMed ID: 18194560
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Occult micrometastases in axillary lymph nodes predict subsequent distant metastases in stage I breast cancer: a case-control study with 15-year follow-up.
    Susnik B; Frkovic-Grazio S; Bracko M
    Ann Surg Oncol; 2004 Jun; 11(6):568-72. PubMed ID: 15150071
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic factors for survival in breast cancer patients who developed distant metastasis subsequent to definitive surgery.
    Kuru B; Camlibel M; Dinc S; Gulcelik MA; Gonullu D; Alagol H
    Singapore Med J; 2008 Nov; 49(11):904-11. PubMed ID: 19037557
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effect of Paget disease on axillary lymph node metastases and survival in invasive ductal carcinoma.
    Wong SM; Freedman RA; Sagara Y; Stamell EF; Desantis SD; Barry WT; Golshan M
    Cancer; 2015 Dec; 121(24):4333-40. PubMed ID: 26376021
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Node-related factors and survival in node-positive breast carcinomas.
    Sivridis E; Giatromanolaki A; Galazios G; Koukourakis MI
    Breast; 2006 Jun; 15(3):382-9. PubMed ID: 16135406
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CD24 expression has a prognostic impact in breast carcinoma.
    Athanassiadou P; Grapsa D; Gonidi M; Athanassiadou AM; Tsipis A; Patsouris E
    Pathol Res Pract; 2009; 205(8):524-33. PubMed ID: 19243896
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Local recurrence in breast carcinoma patients with T(1-2) and 1-3 positive nodes: indications for radiotherapy.
    Yildirim E; Berberoglu U
    Eur J Surg Oncol; 2007 Feb; 33(1):28-32. PubMed ID: 17123771
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
    Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tree-based model for breast cancer prognostication.
    Banerjee M; George J; Song EY; Roy A; Hryniuk W
    J Clin Oncol; 2004 Jul; 22(13):2567-75. PubMed ID: 15226324
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system.
    Flores RM; Routledge T; Seshan VE; Dycoco J; Zakowski M; Hirth Y; Rusch VW
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):605-10. PubMed ID: 18805259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.